Schizophrenia/Psychosis

A recent study from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) investigated the genetics of the auditory event-related potential, a putative psychosis biomarker.

Can schizophrenia be distinguished from bipolar disorder via gray matter volume?

Dr David Osser offers compelling reasons why you might want to take a look at these 7 algorithms, each of which offers actionable consultations-usually in under 2 minutes.

We are in the midst of a paradigm shift in the field, and new diagnostics and treatments that yield clinically significant improvement for the heterogeneous set of disorders known as schizophrenia are being developed.

The need to stay up-to-date with the most current evidence-based information is becoming harder than ever. For this reason, the authors identify and evaluate published research that may have a direct bearing on clinical practice.

Aggressive and impulsive behaviors in schizophrenia pose many clinical challenges. The best way to reduce the risk of aggression is with adequate treatment of schizophrenia.

A paradigm-shifting finding holds the potential to alter how we perceive brain-immune interactions for disorders like schizophrenia and Alzheimer disease. It would enable a more mechanistic approach to the study of the neuroimmunology of these and other disorders.

An analysis of symptom severity across domains may enable us to reevaluate how we categorize symptoms within the spectrum of psychotic illness.

We have many tragic events that affect our collective grieving process. How should they be mourned over time?

A new network-based neuroimaging study seeks to identify biomarkers across the spectrum of impairment in schizophrenia.

Physicians recognize many features of schizophrenia, but one neglected area is the common symptom of a poor self-other boundary-in fact, this has also been neglected as a criterion for the DSM.

Multiple perspectives are required to fully understand a concept. This seems to be the growing consensus with the schizophrenia spectrum disorders.

So many had stared at John Nash, for different reasons, at different times. Now that his own stare is frozen in time, the challenge is to understand the meaning of the stares that he had received during his life.

If the models in this discussion are disseminated and used, costs will drop and patients will enjoy an improved quality of life.

“Those who fail to learn from the mistakes of their predecessors are destined to repeat them.” This may be the take-home point of the APA 2015 meeting regarding schizophrenia.

Progress in identifying and effectively treating first-episode schizophrenia was marked by the simultaneous publication of a report on a 6-year study and on the 10-year follow-up of a large-scale trial.

Here is just a sample of the many great presentations on schizophrenia at this year’s meeting.

In the last 5 years, there has been an absolutely profound transformation in the ability to identify genes that contribute to autism and schizophrenia.

A recent report that argues against descriptive diagnosis in medicine is historically ill-informed and medically naive, in the opinion of this psychiatrist.

A look at a multidisciplinary team -- and its focus on meaningful recovery -- for patients with schizophrenia.

An expert discusses the clinical, biological, and genetic components of de novo mutations and autism spectrum disorders.

We present the case of a patient for whom different attending providers had markedly different interpretations. As the case unfolds, we invite you to reflect on your diagnostic understanding of each presentation.

Metabolic syndrome may be a particularly important marker of antipsychotic metabolic effects.

Identifying comorbid anxiety disorders as potential treatment targets may contribute to more positive outcomes for patients with schizophrenia. Details here.

This article focuses on auditory hallucinations, which occur in a range of psychiatric and medical disorders as well as in individuals without mental illness.

The authors review the evidence for the use of ECT and other novel neurostimulation techniques in the treatment of schizophrenia.

“Distress” hardly captures the inner world of those with severe forms of psychotic illnesses. Terms like “agony,” “torment,” and “anguish” would be much closer to the mark, for many patients.

What signs are generally regarded as negative symptoms? What etiological factors contribute to a negative symptom presentation? How to treat these symptoms? Insights here.

When acute, severe adverse effects from a pre-switch antipsychotic occurs, what strategy is recommended? Take the quiz and learn more.

“Schizophrenia” is a name, not a disease. You are about to read the life story of a remarkable man who describes how he overcame poverty, orphanhood, and schizophrenia to become an author, an LCSW, a leader in the mental health advocacy movement, and an inspiration for many others.